Women’s wellness startup Valerie has raised more than £500k in funding to expand the reach of its perimenopause supplement to a wider audience.
Founders Wizz Selvey and Olly Johnson launched the brand in 2024 to meet growing demand from women for support dealing with perimenopause.
Valerie’s flagship Daily Essential product is sold as an “all-in-one” supplement made with 12 active nutrients, including ashwagandha, B vitamins, zinc and magnesium. The business said the supplement used patent-pending liposomal nanotechnology to improve nutrient absorption and support mood, energy and focus.
A group of angel investors led the £514k pre-seed round, with backing coming from serial investor and former Innocent director Giles Brook.
“Valerie is really well-positioned to become the leading brand in the perimenopause space,” said Brook, who recently added Mighty Slice to his large portfolio of fmcg investments. “It combines authenticity, backed with science, purpose-driven innovation and a unique tone of voice that is delivering outstanding engagement and advocacy with today’s consumer.”
Since launching, Valerie’s sales have grown rapidly, increasing by 84% in the first quarter of 2025 compared with the final three months of 2024, and are on track to exceed £1m this year.
“The category is full of brands that look the same, sound the same and don’t work,” added co-founder Olly Johnson. “We’re building something with real science, real results and a brand and community that women actually want to be part of.”
Selvey said: “We’re not in the business of meno-washing.
“This is not about shrinking into invisibility. It’s about helping women feel like themselves again, with products that actually deliver.”
No comments yet